期刊文献+

阿尔茨海默病的免疫治疗问题 被引量:1

Immunotherapy for Alzheimer's disease
下载PDF
导出
摘要 阿尔茨海默病(Alzheimer disease,AD)是与年龄相关的神经退行性疾病。对其免疫治疗研究取得了可喜的成果,但是也存在着一些困难有待克服。本文对AD的免疫治疗现状、丞待解决的问题和相应的研究对策做一全面分析。 Alzheimer's disease(AD) is an age-related neurodegenerative disease.Immunotherapy holds great promise for AD,but some difficulties still need to be overcome.In this paper,we review recent immunotherapy for AD,problems to be solved and the corresponding countermeasures.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第8期726-728,736,共4页 Immunological Journal
关键词 阿尔茨海默病 免疫 治疗 Alzheimer's disease Immune Therapy
  • 相关文献

参考文献30

  • 1Estadzea MC, Machou C, Berthezene P, et al. Balance sheet of tolerance-efficacy on the use taerine in 100 cases of Alzheimer's disease[J]. Therapie, 1998, 53(1): 67-76.
  • 2Aliev G, Obrenovich ME, Reddy VP, et al. Antioxidant therapy in Alzheimer's disease: theory and practice [J]. Mini Rev Med Chem, 2008, 8(13): 1395-1406.
  • 3Ma X, Gang DR. In vitro production of huperzine A, a promising drug candidate for Alzheimer's disease [J]. Phytochemistry, 2008, 69(10): 2022-2028.
  • 4Gouras GK. Immunotherapy for Alzheimer disease[J]. Mabs, 2009, 1(2): 112-114.
  • 5Morgan D. The role of microglia in antibody-mediated clearance of amyloid-beta from the brain [J]. CNS Neurol Disord Drug Targets, 2009, 8(1): 7-15.
  • 6Poetsch V, Bennani-Baiti B, Neuhaus W, et al. Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro model [J]. Pharmazie, 2010, 65(4): 267-273.
  • 7Mamikonyan G, Necula M, Mkrtichyan M, et al. Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers[J]. J Biol Chem, 2007,282(31): 22376-22386.
  • 8Boado R J, Zhang Y, Zhang Y, et al. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation [J]. Bioconjug Chem, 2007,18(2): 447-455.
  • 9Kontush A, Berndt C, Weber W, et al. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma [J]. Free Radio. Biol. Med, 2001, 30(1): 119-128.
  • 10Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after A β42 immunization[J]. Neurology, 2003, 61(1): 46-54.

二级参考文献14

  • 1赵泽文,梁志清,史常旭,常青,陈勇.抗rhEndoglin单链抗体的可溶性表达、纯化及活性鉴定[J].免疫学杂志,2009,25(1):56-60. 被引量:2
  • 2夏骏,李晓宇,陈秀英,范乐明,陈琪.β淀粉样多肽人源性抗体的筛选与鉴定[J].南京医科大学学报(自然科学版),2004,24(4):328-331. 被引量:3
  • 3Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid- β attenuates Alzheimer-disease-like pathology in the PDAPP mouse[J]. Nature, 1999, 400 (6740): 173-177.
  • 4Dasilva KA, Aubert I, McLaurin J. Vaccine development for Alzheimer's disease [J]. Curr Pharm Des, 2006, 12 (33): 4283-4293.
  • 5Pfeifer M, Boncristiano S, Bondolfi L, etal. Cerebral hemorrhage after passive anti-A β immunotherapy [J]. Science, 2002, 298 (5597): 1379.
  • 6Sblattero D, Bradbury A. A definitive set of oligonueleotide primers for amplifying human V regions[J]. Immunotechnology, 1998, 3 (4): 271-278.
  • 7Liu RT, Yuan B, Emadi S, et al. Single chain variable fragments against β -amyloid (A β ) can inhibit aggregation and prevent A β -induced neurotoxicity [J]. Biochemistry, 2004, 43 (22): 6959-6967.
  • 8Morgan D, Gittler BD. Evidence supporting a role for anti- A β antibodies in the treatment of Alzheimer's disease [J]. Neurobiol Aging, 2004, 25 (5): 605-608.
  • 9Wilcock DM, DiCarlo G, Henderson D, et al. Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation [J]. J Neurosci, 2003, 23 (9): 3745-3751.
  • 10Bacskai B J, Kajdasz ST, McLellan ME, et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid- β in vivo by immunotherapy[J]. J Neurosci, 2002, 22 (18): 7873- 7878.

共引文献5

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部